RxSight, Inc. (RXST), an ophthalmic medical device company, on Tuesday announced that Chief Financial Officer Shelley Thunen is transitioning from her role.
Thunen will remain with the company until the earlier of the appointment of a replacement or January 31, 2026.
Thunen has agreed to continue supporting the company as a consultant following the transition.
The company did not disclose the reason for the transition.
On Monday, RxSight had closed at $12.23, 0.20 cents higher on the Nasdaq. In the after-market hours, the stock traded 1.55 cent lesser before ending the trade at $12.04.
For comments and feedback contact: editorial@rttnews.com
Business News
December 19, 2025 15:10 ET U.S. inflation data and interest rate decisions by major central banks were the highlights of this busy week for economics news flow. Employment data and survey results on the housing markets also gained attention in the U.S. In Europe, the European Central Bank and Bank of England announced their policy decisions and macroeconomic projections.